Literature DB >> 9853759

Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2.

J P Himanen1, M Henkemeyer, D B Nikolov.   

Abstract

The Eph receptors, which bind a group of cell-membrane-anchored ligands known as ephrins, represent the largest subfamily of receptor tyrosine kinases (RTKs). They are predominantly expressed in the developing and adult nervous system and are important in contact-mediated axon guidance, axon fasciculation and cell migration. Eph receptors are unique among other RTKs in that they fall into two subclasses with distinct ligand specificities, and in that they can themselves function as ligands to activate bidirectional cell-cell signalling. We report here the crystal structure at 2.9 A resolution of the amino-terminal ligand-binding domain of the EphB2 receptor (also known as Nuk). The domain folds into a compact jellyroll beta-sandwich composed of 11 antiparallel beta-strands. Using structure-based mutagenesis, we have identified an extended loop that is important for ligand binding and class specificity. This loop, which is conserved within but not between Eph RTK subclasses, packs against the concave beta-sandwich surface near positions at which missense mutations cause signalling defects, localizing the ligand-binding region on the surface of the receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9853759     DOI: 10.1038/24904

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  23 in total

Review 1.  Differential regulation of EphA2 in normal and malignant cells.

Authors:  Jennifer Walker-Daniels; Angela R Hess; Mary J C Hendrix; Michael S Kinch
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

2.  Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets.

Authors:  Nicolas Prévost; Donna S Woulfe; Hong Jiang; Timothy J Stalker; Patrizia Marchese; Zaverio M Ruggeri; Lawrence F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-01       Impact factor: 11.205

Review 3.  Bidirectional ephrin/Eph signaling in synaptic functions.

Authors:  Jason Aoto; Lu Chen
Journal:  Brain Res       Date:  2006-12-12       Impact factor: 3.252

4.  Crystal structure of the human ephrin-A5 ectodomain.

Authors:  Dimitar Nikolov; Chen Li; Martin Lackmann; Philip Jeffrey; Juha Himanen
Journal:  Protein Sci       Date:  2007-03-30       Impact factor: 6.725

5.  Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition.

Authors:  Jill E Chrencik; Alexei Brooun; Michael I Recht; George Nicola; Leila K Davis; Ruben Abagyan; Hans Widmer; Elena B Pasquale; Peter Kuhn
Journal:  J Biol Chem       Date:  2007-09-26       Impact factor: 5.157

6.  Structure of the ligand-binding domain of the EphB2 receptor at 2 A resolution.

Authors:  Yehuda Goldgur; Sari Paavilainen; Dimitar Nikolov; J P Himanen
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-01-31

7.  Crystal structure and NMR binding reveal that two small molecule antagonists target the high affinity ephrin-binding channel of the EphA4 receptor.

Authors:  Haina Qin; Jiahai Shi; Roberta Noberini; Elena B Pasquale; Jianxing Song
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

Review 8.  Homotypic receptor-receptor interactions regulating Eph signaling.

Authors:  Dimitar B Nikolov; Kai Xu; Juha P Himanen
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

Review 9.  Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.

Authors:  S B Noonberg; C C Benz
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

10.  Structural characterization of the EphA4-Ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity.

Authors:  Haina Qin; Roberta Noberini; Xuelu Huan; Jiahai Shi; Elena B Pasquale; Jianxing Song
Journal:  J Biol Chem       Date:  2009-10-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.